dm+d

29896003

Articles

Understanding safety risks with betamethasone soluble tablets used as mouthwash

9 July 2021Serious side effects can be caused if betamethasone soluble tablets used as mouthwash are swallowed. Providing clear patient directions can help prevent harm
Search Articles

Medicine Compliance Aid Stability

genericRPH Pharmaceuticals AB

RPH Pharmaceuticals AB
generic
Tablets soluble 0.5mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soluble tablet unsuitable for MCA
1 November 2022

BetnesolRecipharm Limited (UK)

Recipharm Limited (UK)
Betnesol
Tablets soluble 500microgram
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Soluble tablets so unsuitable for MCA.
25 October 2022

Lactation Safety Information

Oral / Parenteral

Oral / Parenteral
Prednisolone (oral), Hydrocortisone (parenteral)
No published evidence of safety
Used in infants >1 month
Doses up to 8mg daily unlikely to cause adverse effects in the infant
24 September 2020

Local injection

Local injection
Yes
24 September 2020

For ophthalmic use

For ophthalmic use
Yes
There are no additional risks when used in combination ophthalmic preparations containing neomycin
24 September 2020

For use in the ear

For use in the ear
Yes
There are no additional risks when used in combination aural preparations containing neomycin
24 September 2020

For intranasal use

For intranasal use
Yes
24 September 2020

Soluble tablets for orophayngeal use

Soluble tablets for orophayngeal use
Yes
24 September 2020

All esters for topical use

All esters for topical use
Yes
High potency
There are no additional risks when used in combination topical preparations containing antimicrobials or salicylic acid
24 September 2020